Found 34 matching trials
I PREVENT - Irbesartan In Hypertensive Diabetic Patients
PHASE4* To evaluate Blood Pressure (BP) reduction to the targeted values (Systoli...
Location
Sanofi-Aventis Administrative Office
Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
NAIntracerebral hemorrhage (ICH) is the second most common form of stroke, wi...
Location
Princess Margaret Hospital
The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
PHASE4The purpose of this study is to evaluate the blood pressure lowering effect...
Location
Multiple Locations
A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers
PHASE1To compare the pharmacokinetics and safety after a single dose administrati...
Location
Chungbuk National University Hospital
Telmisartan Tab Hypertension
N/ATo assess the efficacy of telmisartan in hypertensive patients with high ca...
Location
Multiple Locations
The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.
NAThe purpose of this study is to evaluate the effects on blood pressure cont...
Location
Multiple Locations
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
PHASE3Both Olmesartan (OLM)/Amlodipine (AML) combination and Hydrochlorothiazide ...
Location
Multiple Locations
Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control
PHASE3The purpose of this study is to evaluate the non-inferiority clinical effic...
Location
Multiple Locations
A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
PHASE1This study is required to confirm the suitability of a candidate FDC of 16m...
Location
GSK Investigational Site
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NAThis project consists of four substudies: a cohort study (A) and a sodium i...